Vaginal self-sampling for human papillomavirus infection as a primary cervical cancer screening tool in a haitian population

Sexually Transmitted Diseases

Volumn 42, Issue 11, 2015, Pages 655-659

  Boggan, Joel C ^a,b,c   Walmer, David K ^a,c   Henderson, Gregory ^c,d   Chakhtoura, Nahida ^a,e   McCarthy, Schatzi H ^c   Beauvais, Harry J ^a,c,f   Smith, Jennifer S ^c,g  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^c Family Health Ministries   (United States)

^d PATH   (United States)

^e UNIVERSITY OF MIAMI HEALTH SYSTEM   (United States)

^f Faculty of Medicine and Health Sciences   (Haïti)

^g University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLPOSCOPY; DIAGNOSTIC TEST ACCURACY STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HAITI; HAITIAN; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PHYSICIAN; PREDICTIVE VALUE; SELF CARE; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR; VIRUS DETECTION; ADOLESCENT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIAL; COMPLICATION; EARLY CANCER DIAGNOSIS; ISOLATION AND PURIFICATION; MASS SCREENING; MULTICENTER STUDY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

VIRUS DNA;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; HAITI; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; SELF CARE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84944238345     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000345     Document Type: Article

References (34)

1. WHO/ICO Information Centre on Human Papilloma Virus (HPV) and Cancer. Human Papillomavirus and Related Cancers in World: Summary Report Update, November 15, 2010. 2010.
2. Villa LL. Cervical cancer in Latin America and the Caribbean: The problem and the way to solutions. Cancer Epidemiol Biomarkers Prev 2012; 21:1409-1413.
3. National Cancer Institute. SEER Stat Fact Sheets: Cervix Uteri Cancer. 2013.
4. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, France: IARC Press, 2001.
5. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr. Accessed May 13, 2014.
6. Walboomers JM, Jacobs MV, Manos MM, et al. Human papilloma-virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
7. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancerin low-and middle-income developing countries. Bull World Health Organ 2001; 79:954-962.
8. Holanda F Jr, Castelo A, Veras TM, et al. Primary screening for cervical cancer through self sampling. Int J Gynaecol Obstet 2006; 95:179-184.
9. Karwalajtys T, Howard M, Sellors JW, et al. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 2006; 82:337-339.
10. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening indeveloping regions: A cross-sectional studyof clinical accuracy in rural China. Lancet Oncol 2008; 9:929-936.
11. Bhatla N, Dar L, Patro AR, et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol 2009; 33:446-450.
12. Belinson JL, Du H, Yang B, et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer 2012; 130:1855-1860.
13. Zhao FH, Lewkowitz AK, Chen F, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst 2012; 104:178-188.
14. Salmerón J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003; 14:505-512.
15. Seo SS, Song YS, Kim JW, et al. Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray. Gynecol Oncol 2006; 102:67-73.
16. Petignat P, Faltin DL, Bruchim I, et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gyneco Oncol 2007; 150:530-535.
17. Twu NF, Yen MS, Lau HY, et al. Type-specific human papillomavirus DNA testing with the genotyping array: A comparison of cervical and vaginal sampling. Eur J Obstet Gynecol Reprod Biol 2011; 156:96-100.
18. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): A community-based randomised controlled trial. Lancet 2011; 378:1868-1873.
19. Snijders PJ, Verhoef VM, Arbyn M, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013; 132:2223-2236.
20. Prins A, Kone A, Nolan N, et al. USAID/Haiti Maternal and Child Health and Family Planning Portfolio Review and Assessment, August 2008. Cambridge, MA: Management Sciences for Health, 2008.
21. Clavel C, Masure M, Bory JP, et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: A preliminary study on 1518 women. Br J Cancer 1999; 80:1306-1311.
22. Darragh TM, Colgan TJ, Cox JT, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 2012; 136:1266-1297.
23. Denny L, Kuhn L, Hu CC, et al. Human papillomavirus-based cervical cancer prevention: Long-term results of a randomized screening trial. J Natl Cancer Inst 2010; 102:1557-1567.
24. Dartell M, Rasch V, Munk C, et al. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania. Sex Transm Dis 2013; 40:737-743.
25. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983; 39:207-215.
26. Greenes RA, Begg CB. Assessment of diagnostic technologies. Methodology for unbiased estimation from samples of selectively verified patients. Invest Radiol 1985; 20:751-756.
27. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province cervical cancer screening study: A cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001; 83:439-444.
28. Belinson JL, Qiao YL, Pretorius RG, et al. Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 2003; 13:819-826.
29. Wright TC Jr, Denny L, Kuhn L, et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283:81-86.
30. Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, et al. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One 2013; 8. e74607.
31. World Health Organization. Task Shifting: Rational Redistribution of Tasks Among Health Workforce Teams: Global Recommendations and Guidelines. Geneva, Switzerland: World Health Organization; 2008.
32. O'Brien MJ, Halbert CH, Bixby R, et al. Community health worker intervention to decrease cervical cancer disparities in Hispanic women. J Gen Intern Med 2010; 25:1186-1192.
33. Elliott PF, Belinson SE, Ottolenghi E, et al. Community health workers, social support and cervical cancer screening among high-risk groups in rural Mexico. J Health Care Poor Underserved 2013; 24:1448-1459.
34. Arrossi S, Thouyaret L, Herrero R, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): A population-based cluster-randomised trial. Lancet Glob Health 2015; 3:e85-e94.